Endocrine News Podcast
by Endocrine Society
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 12 chart positions in 12 markets.
By chart position
- 🇧🇷BR · Medicine#6310K to 30K
- 🇮🇳IN · Medicine#1171K to 10K
- 🇮🇹IT · Medicine#1621K to 10K
- 🇷🇴RO · Medicine#4610K to 30K
- 🇮🇸IS · Medicine#4810K to 30K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
19K to 69K🎙 Weekly cadence·111 episodes·Last published 2w ago - Monthly Reach
Unique listeners across all episodes (30 days)
38K to 138K🇧🇷22%🇷🇴22%🇮🇸22%+9 more - Active Followers
Loyal subscribers who consistently listen
11K to 41K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 12 epsHost
Recent guests
Recent episodes
Bisphenols and the Thyroid
Aug 14, 2026
11m 39s
Impact of Androgen Receptors on Estrogen Receptor-Positive Breast Cancer Microenvironments
Aug 3, 2026
20m 04s
ENP113: Clinical Practice Guideline on Central Precocious Puberty
Jun 25, 2026
17m 40s
ENP112: Osteoporosis and the SABRE Project
May 18, 2026
24m 00s
ENP111: Addressing the Endocrine Workforce Shortage
Feb 25, 2026
30m 12s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 8/14/26 |  Bisphenols and the Thyroid | This episode looks at bisphenols and the thyroid, asking questions such as: What is BPA? Where is it found? And what do we know about the possible health risks regarding exposure to it? Host Aaron Lohr talks with Kailey Caroland, a cancer biology PhD candidate at Vanderbilt University School of Medicine, about her ENDO 2026 abstract on the topic titled, "Bisphenol A, and Alternative Bisphenols S, F, Increase Proliferation and Growth of Thyroid Follicular Epithelial Cells and Disrupt Thyroid Histology." | 11m 39s | ||||||
| 8/3/26 |  Impact of Androgen Receptors on Estrogen Receptor-Positive Breast Cancer Microenvironments | Estrogen receptor positive breast cancer (ER+ BC) is the most frequently diagnosed subtype of BC with consequent highest mortality. For patients with ER+ BC, standard of care treatments are endocrine therapies targeting ER expression and activity or aromatase inhibitors that block synthesis of estrogens from adrenal androgens. However, it is estimated that nearly 33% of all patients with ER+ BC will relapse within 15 years, underscoring the need for additional therapeutic optionsThis episode focuses on the role of androgen receptors in breast cancer, as it takes a look at an abstract presented at ENDO 2026, titled, The Impact of Androgen Receptors on Estrogen Receptor-Positive Breast Cancer Microenvironments. Host Aaron Lohr talks with the presenter of that abstract, Dr. Dillon Boulton, PhD, Postdoctoral fellow in the lab of Dr. Jennifer Richer at the University of Colorado Anschutz Medical Campus. | 20m 04s | ||||||
| 6/25/26 | Central Precocious PubertyClinical Practice Guideline+3 | Ana Latronico, MD, PhDStephanie Roberts, MD | Endocrine SocietySao Paolo University+1 | — | precocious pubertyhormones+4 | — | 17m 40s | ||
| 5/18/26 | osteoporosisclinical trials+4 | Dennis M. BlackRichard Eastell+1 | U.S. Food and Drug AdministrationUniversity of California, San Francisco+3 | — | osteoporosisFDA+5 | — | 24m 00s | ||
| 2/25/26 | endocrine workforce shortageadvanced practice providers+4 | Sara R. MacLeod, DO, MPHShannon K. Idzik, DNP, CRNP, ANP-BC, FAANP, FAAN | Clinical Advantage: Endocrinology Certificate for Advanced Practice ProvidersEndocrine Society+1 | — | endocrinologyworkforce shortage+5 | — | 30m 12s | ||
| 1/21/26 | hypercortisolismtype 2 diabetes+3 | Vivian A. Fonseca, MDJames W. Findling, MD | Endocrine SocietyDiabetes Care+1 | — | hypercortisolismtype 2 diabetes+5 | Corcept Therapeutics Inc. | 20m 03s | ||
| 1/7/26 | anti-obesity medicationspharmacological approaches+3 | Gitanjali Srivastava, MD | Vanderbilt University Medical CenterEndocrine Society | — | anti-obesitymedications+3 | Lilly | 13m 15s | ||
| 12/17/25 | artificial intelligencerobotics+4 | Hassan M. Heshmati, MD | Endocrine SocietyEndocrinology Metabolism Consulting | — | AIrobotics+5 | — | 10m 28s | ||
| 12/3/25 | obesity medicationsGLP-1 drugs+3 | Michael Weintraub, MD | NYU Langone Division of EndocrinologyAmerican Board of Obesity Medicine | — | GLP-1obesity+5 | Lilly | 11m 49s | ||
| 11/12/25 | bariatric surgeryobesity management+3 | Katherine Hazen, MD | University of Rochester Medical Center | — | bariatric surgeryobesity+3 | — | 12m 28s | ||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 10/29/25 | tirzepatidemenopause+3 | Maria Daniela Hurtado Andrade, MD, PhDRegina Castaneda, MD | tirzepatideMayo Clinic Florida+1 | — | tirzepatidemenopause+3 | — | 18m 36s | ||
| 10/15/25 | supplementsendocrine health+3 | Meghana Pattipati, MD | Ochsner Lafayette General Medical CenterFood and Drug Administration | San Francisco | supplementsFDA+3 | — | 10m 47s | ||
| 10/1/25 | Type 1 DiabetesImmunotherapies+3 | Desmond Schatz | Endocrine Society | — | Type 1 DiabetesImmunotherapies+3 | Abbott Diabetes Care | 23m 20s | ||
| 9/17/25 | type 1 diabetesinsulin delivery systems+3 | Grazia Aleppo, MDDiana Isaacs, PharmD | Northwestern University’s Feinberg School of MedicineCleveland Clinic | — | insulin deliverytype 1 diabetes+3 | MannKind Corp. | 31m 56s | ||
| 9/3/25 |  ENP101: Papillary Thyroid Cancer | No description provided. | 9m 52s | ||||||
| 8/13/25 |  ENP100: Growth Hormone Deficiency | No description provided. | 16m 35s | ||||||
| 7/9/25 |  ENP99: Fracture Liaison Services | No description provided. | 19m 17s | ||||||
| 3/19/25 |  ENP98: Opioids and the Endocrine System | No description provided. | 17m 13s | ||||||
| 2/12/25 |  ENP97: Childhood Obesity Treatment | No description provided. | 26m 04s | ||||||
| 12/18/24 |  ENP96: Automated Insulin Delivery Systems | There is a lot of interest in automated insulin delivery systems, and they were covered in depth at the Endocrine Society’s Type 1 Diabetes Fellows Series, held earlier this year. Joining host Aaron Lohr to talk about these delivery systems is Grazia Aleppo, MD, a professor of medicine at Northwestern University and a presenter at the T1D Fellows Series. Show notes are available at https://www.endocrine.org/podcast/enp96-automated-insulin-delivery-systems — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast | 19m 13s | ||||||
| 12/4/24 |  ENP95: Environmental Impact on Early Female Puberty | There are plenty of studies showing that chemicals found in the environment can directly impact human health. Some new research finds that certain environmental compounds may trigger early female puberty. Joining host Aaron Lohr to talk about that research is Natalie Shaw, MD, a Lasker clinical research scholar and principal investigator of the pediatric neuroendocrinology group in the Clinical Research Branch of the National Institute of Environmental Health Sciences. Dr. Shaw and colleagues authored an article recently published in the journal Endocrinology titled, “Identification of Environmental Compounds That May Trigger Early Female Puberty by Activating Human GnRHR and KISS1R.” Show notes are available at https://www.endocrine.org/podcast/enp95-environmental-impact-on-early-female-puberty — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast | 9m 07s | ||||||
| 11/13/24 |  ENP94: Update on Acromegaly | It’s been a few years, but we are here with an update on acromegaly, covering prevalence, diagnosis, traditional treatment, new therapies, and current gaps in understanding. Host Aaron Lohr talks again with Maria Fleseriu, MD, professor of medicine and professor of neurological surgery at Oregon Health & Science University School of Medicine and director of OHSU’s Pituitary Center. Dr. Fleseriu also serves on the Board of Directors of the Endocrine Society. Show notes are available at https://www.endocrine.org/podcast/enp94-update-on-acromegaly — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast | 34m 23s | ||||||
| 10/16/24 |  ENP93: Prioritizing Patient Experience in Managing Diabetes | Host Aaron Lohr talks with Rita Kalyani, MD, professor of medicine at Johns Hopkins University School of Medicine and president-elect of medicine and science at the American Diabetes Association. Earlier this year, Dr. Kalyani and colleagues published a position statement in The Journal of Clinical Endocrinology & Metabolism titled, “Prioritizing Patient Experiences in the Management of Diabetes and Its Complications: An Endocrine Society Position Statement.” Show notes are available at https://www.endocrine.org/podcast/enp93-patience-experience-in-managing-diabetes — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast | 27m 28s | ||||||
| 10/2/24 |  ENP92: Pheochromocytomas | In this episode, we talk about pheochromocytomas. Host Aaron Lohr talks with Nikhitha Chandrashekar, MD, who recently finished her endocrinology fellowship at University Hospitals Case Western Reserve University in Cleveland. Dr. Chandrashekar presented a case study on pheochromocytomas at ENDO 2024. Show notes are available at https://www.endocrine.org/podcast/enp92-pheochromocytomas — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast | 12m 00s | ||||||
| 9/18/24 |  ENP91: Hypothyroidism and Muscle Regeneration | Our bodies typically do a remarkable job of recovering from certain injuries, and thyroid hormone signaling has an essential role to play there. But what is that process like for someone with hypothyroidism, and is there a unique role in that process for muscle stem cells? Host Aaron Lohr talks with Paola Aguiari, PhD, a senior research specialist at Children’s Hospital Los Angeles. She presented an abstract at ENDO 2024 titled, “Hypothyroidism Impairs Skeletal Muscle Regeneration After Injury.” Show notes are available at https://www.endocrine.org/podcast/enp91-hypothyroidism-and-muscle-regeneration — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast | 11m 24s | ||||||
Showing 25 of 113
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for Endocrine News Podcast
Peaked at #46 in RO, currently #46 in RO.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| RO | — | #46 | #46 | — |
| IS | — | #48 | #48 | — |
| Brazil | — | #63 | #63 | — |
| TH | — | #97 | #97 | — |
| PE | — | #104 | #104 | — |
| India | — | #117 | #117 | — |
| TW | — | #122 | #122 | — |
| CL | — | #158 | #158 | — |
| Italy | — | #162 | #162 | — |
| South Africa | — | #166 | #166 | — |
| Denmark | — | #193 | #193 | — |
| CO | — | #194 | #194 | — |
Chart Positions
12 placements across 12 markets.
Chart Positions
12 placements across 12 markets.